Lilly’s weight-loss pill wins US approval

Chronological Source Flow
Back

AI Fusion Summary

Eli Lilly’s tirzepatide, marketed as Mounjaro, has received FDA approval in the U.S. as a weight‑loss medication, offering a new option for obesity treatment after demonstrating significant BMI reduction in clinical trials.
#Eli Lilly #tirzepatide #Mounjaro #FDA approval #weight loss #obesity treatment
01/04 18:49 investing.com
3 Πηγές

Lilly’s weight-loss pill wins US approval

Eli LillytirzepatideMounjaroFDA approvalweight lossobesity treatment
01/04 19:30 wdrb.com

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

POLITICS
01/04 20:02 ft.com

Eli Lilly wins US approval for weight-loss drug in pill form

POLITICS
Comments
Loading...
0